Cite
HARVARD Citation
Gerstein, H. et al. (2018). Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide. Diabetes, obesity & metabolism. 20 (1), pp. 42-49. [Online].